Oncology & Multispecialty — Subtotal
McKesson Oncology & Multispecialty — Subtotal decreased by 1.0% to $301M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 38.7%, from $217M to $301M. Over 2 years (FY 2024 to FY 2026), Oncology & Multispecialty — Subtotal shows an upward trend with a 27.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates growth in the segment's operational scale or profitability, while a decrease signals a contraction or margin pressure.
Detailed definition
Represents the aggregate financial performance or operational sub-total for the Oncology and Multispecialty segment befo...
Peer comparison
Comparable to 'Segment Operating Profit' or 'Segment Revenue' sub-totals reported by peer healthcare distribution companies.
mck_segment_oncology_multispecialty_subtotalHistorical Data
| Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $176.75M | $176.75M | $176.75M | $176.75M | $148M | $200M | $202M | $217M | $212M | $332M | $304M | $301M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -16.3% | +35.1% | +1.0% | +7.4% | -2.3% | +56.6% | -8.4% | -1.0% |
| YoY Change | — | — | — | — | -16.3% | +13.2% | +14.3% | +22.8% | +43.2% | +66.0% | +50.5% | +38.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's oncology & multispecialty — subtotal?
- McKesson (MCK) reported oncology & multispecialty — subtotal of $301M in Q1 2026.
- How has McKesson's oncology & multispecialty — subtotal changed year-over-year?
- McKesson's oncology & multispecialty — subtotal increased by 38.7% year-over-year, from $217M to $301M.
- What is the long-term trend for McKesson's oncology & multispecialty — subtotal?
- Over 2 years (2024 to 2026), McKesson's oncology & multispecialty — subtotal has grown at a 27.5% compound annual growth rate (CAGR), from $707M to $1.15B.
- What does oncology & multispecialty — subtotal mean?
- The combined financial sub-total for the Oncology and Multispecialty business segment.